TCG attends life science industry meetings each year in the US and Europe and participates in panels and webinars.
TCG Partner Charlie Turner Acted As Interim Business Development Leader in Key Transaction for Baxter International
Chapel Hill, NC - Initial trial results from Baxter hemophilia gene therapy program come from acquired affiliate of AskBio of Chapel Hill; TCG Partner Charlie Turner acted as interim business development leader in key transaction. Click here to download press…